Development of a Computer Assisted Survivor Screening For Adult Survivors of Childhood Cancer

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00579293

Enrollment

100

Registered

2007-12-24

Start date

2004-08-31

Completion date

2008-07-31

Last updated

2008-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Childhood Cancer

Keywords

adult survivor of childhood cancer, computer assisted screening of survivors (CASS)

Brief summary

This study will compare two ways of having people respond to a questionnaire about health and emotional well-being: on a computer and with paper and pencil. We will see how long it takes using both methods. We will also ask you how you feel about using a computer to answer the questions.

Detailed description

To determine feasibility of using the Computer Assisted Survivor Screening (CASS) as a routine screening measure for the survivor population. Specifically, to determine patient acceptance, time to completion, and burden associated with the CASS. To examine the potential utility of the CASS as a routine screening measure in the survivor population. To validate the CASS against the SCL-90-R screening measure. Calculate the sensitivity,specificity, positive and negative predictive values, diagnostic agreement and ROC curve of the CASS compared to the SCL-90. Determine the optimal cut-off scores to optimize agreement between the CASS and the SCL-90.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 49 Years

Healthy volunteers

Inclusion criteria

* Currently at least 18 years of age and not older than 49 years of age * Diagnosed with first malignancy before the age of 22 * Completed all cancer treatment at least three years prior * Able to complete the survey instruments in English * Scheduled for a routine off-treatment follow-up oncology appointment * Currently disease-free and not receiving any cancer treatment

Exclusion criteria

* History of a central nervous system tumor * A sensory or cognitive impairment that would interfere with completion of the survey * Currently undergoing treatment by a psychiatrist or psychologist (ie., currently receiving psychotherapy and/or psychotropic medications, as per self-report)

Countries

United States

Outcome results